VANCOUVER, BRITISH COLUMBIA--(Marketwire - December 01, 2008) - Pacgen Biopharmaceuticals Corporation (“Pacgen” or the “Company”) (TSX VENTURE: PGA) today reported financial results from its second fiscal quarter ended September 30, 2008. Amounts unless specified otherwise, are expressed in Canadian dollars and in accordance with Canadian Generally Accepted Accounting Principles (Canadian GAAP).
